Jori S. Carter1, Navneeth Lakkadi2,
Jessica E. Kuehn-Hajder3, Isabelle V. Iltis2, Levi S.
Downs, Jr.1, Patrick J. Bolan2
1Obstetrics, Gynecology,
& Women's Health, University of Minnesota, Minneapolis, MN, United
States; 2Radiology/CMRR, University of Minnesota, Minneapolis, MN,
United States; 3Radiology, University of Minnesota, Minneapolis,
MN, United States
Malignant ovarian masses can be differentiated from benign ovarian masses with the use of multiple, quantitative MR-based metrics at 3 Tesla, including T2, ADC, IAUC, and MRS. These preliminary results indicate that IAUC values from dynamic contrast-enhanced images and the detection of total choline-containing compounds by MRS can differentiate between malignant and benign masses. A larger population is needed to show if there is a difference for T2 values.